Antagonism of striatal muscarinic receptors inhibiting dopamine D1 receptor-stimulated adenylyl cyclase activity by cholinoceptor antagonist used to treat Parkinson's disease.
about
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout miceSensing Positive versus Negative Reward Signals through Adenylyl Cyclase-Coupled GPCRs in Direct and Indirect Pathway Striatal Medium Spiny Neurons.Cholinergic connectivity: it's implications for psychiatric disorders.Effects of muscarinic acetylcholine receptor activation on membrane currents and intracellular messengers in medium spiny neurones of the rat striatum.
P2860
Antagonism of striatal muscarinic receptors inhibiting dopamine D1 receptor-stimulated adenylyl cyclase activity by cholinoceptor antagonist used to treat Parkinson's disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@en
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@nl
type
label
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@en
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@nl
prefLabel
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@en
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@nl
P2860
P1476
Antagonism of striatal muscari ...... to treat Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15474.X
P407
P577
1996-06-01T00:00:00Z